SYNTH ANATOMY

Xils Lab MemoryTone: the year of the Memorymoog emulation isn’t yet over

Xils Lab Memorytone is a new authentic Moog Memorymoog Synthesizer emulation and joins the others this year. The year 2026 ...
quantumzeitgeist

Scaling up qubit count makes detuning harder, boosts crosstalk

As superconducting quantum processors reach the thousand-qubit regime, increasing qubit count makes detuning more challenging ...

Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant ...

ENIGMA-TRS 1 is a Phase 3 international, one-year, randomized, double-blind, placebo-controlled study in 600+ patients; 12-week study results ...
boerse.de

EQS-News: Newron schließt Screening für Rekrutierung in pivotale Phase-3-Studie ENIGMA-TRS 1 ab, in der Evenamide als Zusatztherapie bei Patienten mit behandlu…

Newron schließt Screening für Rekrutierung in potenziell zulassungsrelevante Phase-3-Studie ENIGMA-TRS 1 ab, in der Evenamide ...

EQS-News: Newron schließt Screening für Rekrutierung in pivotale Phase-3-Studie ENIGMA-TRS 1 ab, in der Evenamide als Zusatztherapie bei Patienten mit behandlu…

Newron schließt Screening für Rekrutierung in pivotale Phase-3-Studie ENIGMA-TRS 1 ab, in der Evenamide als Zusatztherapie ...
quantumzeitgeist

Quantum scientists map exciton wave functions in organic films

Excitons, correlated electron-hole pairs governing optical and transport properties in organic semiconductors, have long resisted direct experimental access to their full quantum-mechanical wave ...

Pyrotech Therapeutics Doses First Subject in Phase 1 Study of PTT-121, the World's First Selective GSDMD Inhibitor to Enter Clinical Development

Pyrotech Therapeutics ("Pyrotech" or the "Company"), a clinical-stage biopharmaceutical company pioneering innate immune modulation and pyroptosis-targeted therapies, announced that the first healthy ...